MDS Inc. Tampa Operations acquired by Xcelience, LLC

WEST CONSHOHOCKEN, PA. – May 11, 2006 – MDS Inc. (TSX: MDS; NYSE: MDZ) (“MDS”), based in Toronto, Canada, completed the divestiture of their Tampa-based drug development operations. That operation, which provides pre-formulation, formulation, analytical and manufacturing and packaging services, was purchased by Xcelience, LLC in a management buyout led by industry veterans Derek Hennecke […]